跳至主要内容
临床试验/ITMCTR2100005185
ITMCTR2100005185尚未招募4 期

Clinical application of Bailing tablet in the treatment of chronic obstructive pulmonary disease in post-epidemic era

Huzhou Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
45 至 80(—)
性别
All

入选标准

  • 1. Meet the diagnostic criteria for chronic obstructive pulmonary disease, and TCM syndrome differentiation belongs to the lung and kidney deficiency type;
  • 2. Aged 45-80 years;
  • 3. Voluntarily participate in clinical research and sign the informed consent;
  • 4. Outpatients.

排除标准

  • 1. Combined with more serious primary diseases such as heart, kidney, liver, brain, hematopoietic system;
  • 2. Pregnant or lactating patients;
  • 3. Those who cannot cooperate and have severe cognitive impairment;
  • 4. History of glucocorticoid or p-receptor agonist use within the past 1 month;
  • 5. Patients with contraindications to the study drug.

研究者

发起方
Huzhou Hospital of Traditional Chinese Medicine

相似试验